Continued cost recovery is the aim of proposed medtech user fee rises by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The hikes would take effect in April 2025.
A seven-week consultation closing 24 October allows stakeholders to give their views on what one regulatory specialist, commenting on social...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?